These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Identification and characterization of 4-chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a selective and irreversible peroxisome proliferator-activated receptor delta (PPARdelta) antagonist. Shearer BG; Wiethe RW; Ashe A; Billin AN; Way JM; Stanley TB; Wagner CD; Xu RX; Leesnitzer LM; Merrihew RV; Shearer TW; Jeune MR; Ulrich JC; Willson TM J Med Chem; 2010 Feb; 53(4):1857-61. PubMed ID: 20128594 [TBL] [Abstract][Full Text] [Related]
5. The PPARδ ligand L-165041 inhibits VEGF-induced angiogenesis, but the antiangiogenic effect is not related to PPARδ. Park JH; Lee KS; Lim HJ; Kim H; Kwak HJ; Park HY J Cell Biochem; 2012 Jun; 113(6):1947-54. PubMed ID: 22234939 [TBL] [Abstract][Full Text] [Related]
6. Increase of human prostate cancer cell (DU145) apoptosis by telmisartan through PPAR-delta pathway. Wu TT; Niu HS; Chen LJ; Cheng JT; Tong YC Eur J Pharmacol; 2016 Mar; 775():35-42. PubMed ID: 26852954 [TBL] [Abstract][Full Text] [Related]
7. Activation of PPARdelta inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts. Teunissen BE; Smeets PJ; Willemsen PH; De Windt LJ; Van der Vusse GJ; Van Bilsen M Cardiovasc Res; 2007 Aug; 75(3):519-29. PubMed ID: 17543901 [TBL] [Abstract][Full Text] [Related]
8. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis. Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742 [TBL] [Abstract][Full Text] [Related]
9. PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC. Kim MJ; Choi YK; Park SY; Jang SY; Lee JY; Ham HJ; Kim BG; Jeon HJ; Kim JH; Kim JG; Lee IK; Park KG Mol Cancer Res; 2017 Sep; 15(9):1230-1242. PubMed ID: 28584024 [TBL] [Abstract][Full Text] [Related]
10. Metformin inhibits PPARδ agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cells. Ding J; Gou Q; Jin J; Shi J; Liu Q; Hou Y Eur J Pharmacol; 2019 Aug; 857():172425. PubMed ID: 31150647 [TBL] [Abstract][Full Text] [Related]
12. PPARδ signaling regulates colorectal cancer. You M; Yuan S; Shi J; Hou Y Curr Pharm Des; 2015; 21(21):2956-9. PubMed ID: 26004416 [TBL] [Abstract][Full Text] [Related]
13. Antiproliferative effects of some N-benzylideneanilines. Ozkay Y; Incesu Z; Işikdağ I; Yeşilkaya M Cell Biochem Funct; 2008; 26(1):102-6. PubMed ID: 17457959 [TBL] [Abstract][Full Text] [Related]
14. PPARdelta mediates IL15 metabolic actions in myotubes: effects of hyperthermia. Fuster G; Busquets S; Figueras M; Ametller E; Fontes de Oliveira CC; Oliván M; Grimaldi PA; Argilés JM; López-Soriano FJ Int J Mol Med; 2009 Jul; 24(1):63-8. PubMed ID: 19513536 [TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) is highly expressed in liposarcoma and promotes migration and proliferation. Wagner KD; Benchetrit M; Bianchini L; Michiels JF; Wagner N J Pathol; 2011 Aug; 224(4):575-88. PubMed ID: 21598253 [TBL] [Abstract][Full Text] [Related]
16. Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancer. Daikoku T; Tranguch S; Chakrabarty A; Wang D; Khabele D; Orsulic S; Morrow JD; Dubois RN; Dey SK Cancer Res; 2007 Jun; 67(11):5285-92. PubMed ID: 17545608 [TBL] [Abstract][Full Text] [Related]
17. PPARgamma inhibitors reduce tubulin protein levels by a PPARgamma, PPARdelta and proteasome-independent mechanism, resulting in cell cycle arrest, apoptosis and reduced metastasis of colorectal carcinoma cells. Schaefer KL; Takahashi H; Morales VM; Harris G; Barton S; Osawa E; Nakajima A; Saubermann LJ Int J Cancer; 2007 Feb; 120(3):702-13. PubMed ID: 17096328 [TBL] [Abstract][Full Text] [Related]
18. Sirtuin 1 Mediates the Actions of Peroxisome Proliferator-Activated Receptor δ on the Oxidized Low-Density Lipoprotein-Triggered Migration and Proliferation of Vascular Smooth Muscle Cells. Hwang JS; Ham SA; Yoo T; Lee WJ; Paek KS; Lee CH; Seo HG Mol Pharmacol; 2016 Nov; 90(5):522-529. PubMed ID: 27573670 [TBL] [Abstract][Full Text] [Related]